Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”

Ítems similars

• Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”
  per: Gotkine, Marc, et al.
  Publicat: (2015)
• Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice
  per: Gotkine Marc, et al.
  Publicat: (2013-01-01)
• Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice
  per: Marc, Gotkine, et al.
  Publicat: (2013)
• Cerebrospinal Fluid Defines SOD1 as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
  per: Winer, Leah, B.A., et al.
  Publicat: (2013)
• Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression
  per: Apolloni, Savina, et al.
  Publicat: (2016)